Pete’s medication and experience

One person’s treatment.
The need behind the rules.

A personal account from Pete, connecting the medicines in his existing profile with the practical experience behind JBD’s research.

The recorded
daily medicines.

Pete confirmed on 26 October 2026 that the medicines in his existing profile have not changed.

Existing profile

Venlafaxine

240 mg/day

Existing profile

Diazepam

15 mg/day

Existing profile

Propranolol

160 mg/day

Personal medication details retained from Pete’s existing published profile. These are his recorded medicines, not treatment instructions for other readers.
The experience described

Daily need.
Episodic symptoms.

Pete’s existing account describes using small amounts of cannabis repeatedly when neurological symptoms arise. It records 20–25 grams of flower over four to six weeks, with day-to-day use varying.

The earlier illustration used flower described as 24% THC and estimated 0.05–0.10 grams per episode. Those are the figures recorded in the account, rather than new measurements made for this page.

Clasped hands, used as contextual imagery

Put the numbers in context.

Different medicines can all be measured in milligrams. That common unit does not make their clinical effects or risks equivalent. This page does not use the relative mass of different substances as proof that one treatment is stronger, safer or more proportionate than another.

Pete’s account describes his experience and why continuity of care matters to him. The report’s legal and policy findings are supported separately by the original records and analysis.